Exoskeleton Market Growth

Exoskeleton market growth is expected at a CAGR of 20.8% during the period 2026-2035

 

According to a recently published report by Roots Analysis, the growing prevalence of neurological disorders, workplace injuries and an ageing population is driving the growth of non-medical and medical exoskeleton market

Global Exoskeleton Industry Overview

The global exoskeleton market is anticipated to grow at a CAGR of 20.8% from 2026-2035, reaching USD 20.3 billion by 2035.

Exoskeleton technology is a promising tool that assists over one billion people, worldwide, with neurological disorders and associated disabilities. These devices combat mobility issues (hemiplegia, paraplegia and quadriplegia) while reducing hospital costs. In addition, they are known to decrease muscle fatigue by 50% in industries, such as production and shipping lines. Ongoing advances in robotics, artificial intelligence (AI), virtual reality (VR), and machine learning (ML), along with efforts to make the exoskeleton technology more effective and affordable, are set to drive widespread adoption of exoskeleton in the near future.

Browse 150+ figures and 190+ market data tables spread across 400+ pages and detailed Table of Content on “Global Exoskeleton Market by Body Part Covered, Mode of Operation, Form of Exoskeleton, Mobility, End Users and Geography: Industry Trends and Global Forecasts, 2026-2035” here: https://www.rootsanalysis.com/reports/exoskeleton-market.html

Market Drivers

Several factors are influencing the adoption of exoskeleton technology. As the global population continues to age, there is a growing need for solutions to assist people with mobility issues and age-related conditions. Medical exoskeletons can provide support to older individuals to maintain an active, independent lifestyle, engage with others and enjoy an improved quality of life. The applications of exoskeletons have expanded from mobility assistance previously, to their active utilization in healthcare for rehabilitation and improving the lives of individuals with physical disabilities. In addition, exoskeletons provide several benefits in industrial and military sectors. This can be attributed to their role in performance enhancement and reducing the risk of injuries. Furthermore, exoskeletons are also finding roles in sports, everyday assistive devices, and physically demanding industries. In the foreseen future, the adoption rate of this nascent technology is anticipated to steadily increase as the stakeholders recognize the positive return on investment (ROI) on exoskeleton technology (owing to higher benefit-cost ratio) and established distribution networks reach the new potential customers.

Market Restraints

There are number of exoskeletons which are currently commercialized for various purposes, the adoption rates in the industry still remain a challenge owing to several reasons, such as their high cost, limited awareness and lack of customization. Further, exoskeleton technology may have limitations in terms of battery life, weight, and adaptability to different environments, which can affect their practicality and effectiveness. Insurance coverage for exoskeletons is not uniform across regions or providers. This lack of established reimbursement models for exoskeletons can be a deterrent for end users. There is a lack of randomized clinical data, specifically regarding the long-term benefits of the product when used within clinical settings, as the trials conducted to date for many exoskeletons have been limited. As a result, potential customers and healthcare providers may exhibit hesitancy in adopting the exoskeleton technology.

Growth Factors

Despite the challenges, several growth factors continue to drive the global exoskeleton market forward. The innovations in exoskeleton technologies in various aspects, such as integration of artificial intelligence, deep learning, Internet of Things (IIoT), flexible designs, and smart sensors has driven higher adoption of exoskeletons for various applications such as treatment of various neurological disorders as well as enhancing productivity of workers in industries. Interestingly, the exoskeleton companies are transitioning from rigid exoskeletons to soft, lightweight exoskeletons, to allow more comfort to the user, resulting in its higher adoption and subsequently, a substantial growth of the overall exoskeletons market. In the near to mid-term, the anticipated adoption of devices with advanced features is likely to drive growth in this market.

Global Exoskeleton Market Segments

Based on the body part covered, the non-medical and medical exoskeleton market is segmented into Upper Extremity, Lower Extremity and Full Body.

• The medical exoskeleton market for lower body led the market, capturing the largest revenue share of close to 55.0%.
• The full body segment is anticipated to show the highest growth potential (over 22% annually) in the market during the forecast period.
• Within the non-medical exoskeleton market, the upper body segment led the market, capturing the largest revenue share of more than 68.0%.
• The lower body segment is anticipated to show the highest growth potential in the market during the forecast period of over 30% annually.

Based on the mode of operation, the non-medical and medical exoskeleton market is segmented into Powered, Passive and Hybrid.

• Within the medical exoskeleton market, the powered segment led the market, capturing the largest revenue share of nearly 70.0%.
• Within the non-medical exoskeleton market, the passive segment led the market, capturing the largest revenue share of nearly 55.0%.
• The passive segment is anticipated to show the highest annual growth potential of over 25% and 19% in market, respectively during the forecast period.

Based on the form, the non-medical and medical exoskeleton market is segmented into Soft and Rigid.

• The rigid exoskeletons led both the non-medical and medical exoskeleton market, capturing the largest revenue share of nearly 60% and 18%, respectively.
• Within the market, the soft segment is anticipated to show the highest growth potential during the forecast period of over 19%, annually.
• However, within the non-medical exoskeleton market, the rigid segment is anticipated to show the highest growth potential during the forecast period of over 24% annually.

Based on mobility, the medical exoskeleton market is segmented into Fixed / Supported and Mobile.

• The mobile exoskeletons led the medical exoskeleton market, capturing the largest revenue share of more than 65.0%.
• Owing to development and subsequent approvals of mobile exoskeleton possessing a range of applications, this segment is anticipated to show the highest growth potential of over 22% annually during the forecast period.

Based on End Users, the medical exoskeleton market is segmented into Patients and Healthcare Providers

• The patients segment led the market, capturing the largest revenue share of more than 90.0%.
• As exoskeleton companies develop and commercialize devices intended to be used for patients with different neurological and motor disorders, this segment is anticipated to possess the highest growth potential of over 21% annually during the forecast period.

Based on End Users, the non-medical exoskeleton market is segmented into Military, Industrial and Others

• The industrial exoskeleton segment led the non-medical exoskeleton market, capturing the largest revenue share of more than 50.0%.
• The exoskeletons, intended for military applications, are likely to possess the highest growth potential of over 21% annually in the non-medical exoskeleton market during the forecast period.

Based on the regional insights, the non-medical and medical exoskeleton market is segmented into North America, Europe and Asia-Pacific.

• North America dominated the overall market and accounted for the largest revenue share of nearly 38.0%.
• In Asia-Pacific, the overall exoskeleton market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The market report also includes detailed profiles of key exoskeleton companies (listed below) that have been shortlisted based on the number and application area of exoskeletons in their product portfolio:

• Bionic Yantra
• CYBERDYNE
• Ekso Bionics
• ExoAtlet
• Fourier Intelligence
• Gloreha
• Guangzhou Yikang Medical Equipment
• Hexar Humancare
• Hocoma
• MediTouch
• Milebot Robotics
• Myomo
• Neofect
• NextStep Robotics
• Panasonic
• ReWalk Robotics
• Rex Bionics
• Roam Robotics
• Trexo Robotics
• Tyromotion
• U&O Technologies

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/exoskeleton-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com